Literature DB >> 11533315

Glutamine alimentation in catabolic state.

P G Boelens1, R J Nijveldt, A P Houdijk, S Meijer, P A van Leeuwen.   

Abstract

Glutamine should be reclassified as a conditionally essential amino acid in the catabolic state because the body's glutamine expenditures exceed synthesis and low glutamine levels in plasma are associated with poor clinical outcome. After severe stress, several amino acids are mobilized from muscle tissue to supply energy and substrate to the host. Glutamine is one of the most important amino acids that provide this function. Glutamine acts as the preferred respiratory fuel for lymphocytes, hepatocytes and intestinal mucosal cells and is metabolized in the gut to citrulline, ammonium and other amino acids. Low concentrations of glutamine in plasma reflect reduced stores in muscle and this reduced availability of glutamine in the catabolic state seems to correlate with increased morbidity and mortality. Adding glutamine to the nutrition of clinical patients, enterally or parenterally, may reduce morbidity. Several excellent clinical trials have been performed to prove efficacy and feasibility of the use of glutamine supplementation in parenteral and enteral nutrition. The increased intake of glutamine has resulted in lower septic morbidity in certain critically ill patient populations. This review will focus on the efficacy and the importance of glutamine supplementation in diverse catabolic states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533315     DOI: 10.1093/jn/131.9.2569S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  24 in total

1.  Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets.

Authors:  S Carobbio; H Ishihara; S Fernandez-Pascual; C Bartley; R Martin-Del-Rio; P Maechler
Journal:  Diabetologia       Date:  2003-12-20       Impact factor: 10.122

2.  Glutamine Supplementation did not Benefit Athletes During Short-Term Weight Reduction.

Authors:  Kevin J Finn; Robin Lund; Mona Rosene-Treadwell
Journal:  J Sports Sci Med       Date:  2003-12-01       Impact factor: 2.988

Review 3.  Current trends in critical care nutrition.

Authors:  Jinesh P Mehta; Bashar Chihada Alhariri; Mihir Kishorchandra Patel
Journal:  Curr Gastroenterol Rep       Date:  2011-08

4.  The role of skeletal muscle in liver glutathione metabolism during acetaminophen overdose.

Authors:  L M Bilinsky; M C Reed; H F Nijhout
Journal:  J Theor Biol       Date:  2015-04-16       Impact factor: 2.691

5.  Effects of branched amino acids supplementation in malnourished elderly with catabolic status.

Authors:  M Bonnefoy; M Laville; R Ecochard; J F Jusot; S Normand; S Maillot; B Lebreton; M Jauffret
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

6.  Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury.

Authors:  Hong Yan; Yong Zhang; Shang-jun Lv; Lin Wang; Guang-ping Liang; Qian-xue Wan; Xi Peng
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

7.  The effect of glutamine on pancreatic damage in TNBS-induced colitis.

Authors:  Cumhur Değer; Yeşim Erbil; Murat Giriş; Burcu Tulumoglu Yanik; Fatih Tunca; Vakur Olgaç; Semra Doğru Abbasoğlu; Serdar Oztezcan; Gülçin Toker
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

8.  The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.

Authors:  Yan Gu; Zhao-Han Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Design, synthesis, and biological activity of novel triazole amino acids used to probe binding interactions between ligand and neutral amino acid transport protein SN1.

Authors:  Mariusz Gajewski; Ben Seaver; C Sean Esslinger
Journal:  Bioorg Med Chem Lett       Date:  2007-05-23       Impact factor: 2.823

Review 10.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.